Table 2.

Mastitis characteristics and medication use (mITT).

	Placebo (N = 22)	Probiotic (N = 9)
Fever due to mastitis
Absent n (%)	13 (59.1%)	4 (44.4%)
Present n (%)	6 (27.3%)	5 (55.6%)
Unspecified n (%)	3 (13.6%)	0 (0.0%)
Duration of mastitis episodes, days †	15.0 (11.0, 22.0)	16.0 (10.0–18.0)
Antibiotic use
Yes n (%)	16 (72.7%)	4 (44.4%)
No n (%)	6 (27.3%)	5 (55.6%)
Anti-inflammatory drugs
Yes, n (%)	15 (68.2%)	7 (77.8%)
No n (%)	7 (31.8%)	2 (22.2%)
Other
Yes n (%)	2 (9.1%)	2 (22.2%)
No n (%)	20 (90.9%)	7 (77.8%)

N = number of mastitis episodes; n = number of subjects per category. ^†: data reported in median (Q1, Q3).